ARMC
American Research & Management Company Portfolio holdings
AUM
$362M
1-Year Return
8.06%
This Quarter Return
-9.75%
1 Year Return
-8.06%
3 Year Return
+35.07%
5 Year Return
+60.97%
10 Year Return
–
AUM
$297M
AUM Growth
-$40.3M
(-12%)
Cap. Flow
-$2.76M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
35.05%
Holding
362
New
12
Increased
34
Reduced
87
Closed
28
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.5M |
| 2 |
Amazon
AMZN
|
+$1.15M |
| 3 |
Roper Technologies
ROP
|
+$1.02M |
| 4 |
Energy Transfer Partners
ET
|
+$990K |
| 5 |
Estee Lauder
EL
|
+$509K |
Top Sells
| 1 |
IBM
IBM
|
+$1.22M |
| 2 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$928K |
| 3 |
CELG
Celgene Corp
CELG
|
+$508K |
| 4 |
Kinder Morgan
KMI
|
+$506K |
| 5 |
Altria Group
MO
|
+$465K |
Sector Composition
| 1 | Technology | 22.58% |
| 2 | Healthcare | 15.32% |
| 3 | Consumer Staples | 14.98% |
| 4 | Financials | 10.25% |
| 5 | Energy | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Automatic Data Processing
ADP
$120B
| $3.39M | 1.14% |
25,814
-310
| -1% | -$40.7K |
|
27
Philip Morris
PM
$263B
| $3.15M | 1.06% |
47,124
-4,753
| -9% | -$317K |
|
28
Biogen
BIIB
$21.5B
| $3.13M | 1.05% |
10,390
-25
| -0.2% | -$7.52K |
|
29
McCormick & Company Non-Voting
MKC
$18.8B
| $3.08M | 1.04% |
44,270
-600
| -1% | -$41.8K |
|
30
Stryker
SYK
$148B
| $2.75M | 0.93% |
17,560
-430
| -2% | -$67.4K |
|
31
Microsoft
MSFT
$3.72T
| $2.73M | 0.92% |
26,860
-950
| -3% | -$96.5K |
|
32
John Wiley & Sons Class A
WLY
$2.22B
| $2.43M | 0.82% |
51,800
-850
| -2% | -$39.9K |
|
33
Teleflex
TFX
$5.84B
| $2.42M | 0.82% |
9,375
-384
| -4% | -$99.2K |
|
34
Toronto Dominion Bank
TD
$131B
| $2.28M | 0.77% |
45,786
-550
| -1% | -$27.3K |
|
35
NVIDIA
NVDA
$4.32T
| $2.21M | 0.74% |
660,600
-20,400
| -3% | -$68.1K |
|
|
USB.PRM
36
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
| $2.16M | 0.73% |
81,575
-1,300
| -2% | -$34.4K |
|
37
Berkshire Hathaway Class B
BRK.B
$1.07T
| $2.08M | 0.7% |
10,170
-325
| -3% | -$66.4K |
|
38
Merck
MRK
$213B
| $2.08M | 0.7% |
28,479
-944
| -3% | -$68.8K |
|
39
DuPont de Nemours
DD
$32.6B
| $1.99M | 0.67% |
18,468
-565
| -3% | -$61K |
|
40
RTX Corp
RTX
$210B
| $1.97M | 0.67% |
29,446
+153
| +0.5% | +$10.3K |
|
41
Pfizer
PFE
$141B
| $1.96M | 0.66% |
47,314
-105
| -0.2% | -$4.35K |
|
42
TC Energy
TRP
$54.2B
| $1.87M | 0.63% |
52,229
-600
| -1% | -$21.4K |
|
43
Vertex Pharmaceuticals
VRTX
$102B
| $1.86M | 0.63% |
11,200
| – | – |
|
44
HCI Group
HCI
$2.36B
| $1.85M | 0.62% |
36,400
-300
| -0.8% | -$15.2K |
|
45
Helmerich & Payne
HP
$2.05B
| $1.6M | 0.54% |
33,335
-8,010
| -19% | -$384K |
|
46
ResMed
RMD
$40.1B
| $1.53M | 0.52% |
13,415
-200
| -1% | -$22.8K |
|
|
47
Estee Lauder
EL
$31.4B
| $1.48M | 0.5% |
11,370
+3,915
| +53% | +$509K |
|
48
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$30.8B
| $1.44M | 0.49% |
12,760
-800
| -6% | -$90.3K |
|
49
Gilead Sciences
GILD
$145B
| $1.33M | 0.45% |
21,190
-7,170
| -25% | -$448K |
|
50
Hormel Foods
HRL
$13.9B
| $1.33M | 0.45% |
31,055
+775
| +3% | +$33.1K |
|